ExLibris header image
SFX Logo
Title: Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes
Source:

Science [0036-8075] Ambrus, C M yr:1978


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Watanabe, S K. "Phenylalanine ammonia lyase from Sporidiobolus pararoseus and Rhodosporidium toruloides: Application for phenylalanine and tyrosine deamination." World journal of microbiology & biotechnology 8.4 (1992): 406-410. Link to Full Text for this item Link to SFX for this item
2. Mizock, B A A. "Nutritional support in hepatic encephalopathy." Nutrition 15.3 (1999): 220-8. Link to SFX for this item
3. Thomson, Rebecca L. "Protein hydrolysates and tissue repair." Nutrition research reviews 24.2 (2011): 191-197. Link to SFX for this item
4. Kondrup, J. "Energy and protein requirements of patients with chronic liver disease." Journal of Hepatology 27.1 (1997): 239-247. Link to Full Text for this item Link to SFX for this item
5. Hashimoto, M. "Novel photoreactive cinnamic acid analogues to elucidate phenylalanine ammonia-lyase." Bioorganic & medicinal chemistry letters 10.21 (2000): 2481-2483. Link to Full Text for this item Link to SFX for this item
6. Kalaitzakis, E. "Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life." Scandinavian journal of gastroenterology 41.12 (2007): 1464-72. Link to SFX for this item
7. Córdoba, J. "Normal protein diet for episodic hepatic encephalopathy: results of a randomized study." Journal of Hepatology 41.1 (2004): 38-43. Link to SFX for this item
8. Ajithkumar, T. "Ifosfamide encephalopathy." Clinical Oncology 19.2 (2007): 108-14. Link to SFX for this item
9. Kim, W. "Trends in Enzyme Therapy for Phenylketonuria." Molecular therapy 10.2 (2004): 220-4. Link to SFX for this item
10. Yesne Alici-Evcimen, William S. Breitbart, William S S. "Ifosfamide neuropsychiatric toxicity in patients with cancer." Psycho-oncology 16.10 (2007): 956-60. Link to Full Text for this item Link to SFX for this item
11. Patel, Priti N N. "Methylene blue for management of Ifosfamide-induced encephalopathy." The Annals of pharmacotherapy 40.2 (2006): 299-303. Link to SFX for this item
12. Hamadani, M. "Role of thiamine in managing ifosfamide-induced encephalopathy." Journal of oncology pharmacy practice 12.4 (2007): 237-9. Link to Full Text for this item Link to SFX for this item
13. Phillips, Stuart M. "Dietary protein for athletes: from requirements to optimum adaptation." Journal of sports sciences 29.29 (2011): 10-10. Link to SFX for this item
14. Küpfer, A. "Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue." The lancet 343.8900 (1994): 763-4. Link to SFX for this item
15. Plauth, M. "ESPEN guidelines for nutrition in liver disease and transplantation." Clinical Nutrition 16.2 (1997): 43-55. Link to Full Text for this item Link to SFX for this item
16. Hviid, L. "Malaria immunity in infants: a special case of a general phenomenon?" Trends in parasitology 20.2 (2004): 66-72. Link to SFX for this item
17. Gámez, A. "Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria." Molecular therapy 11.6 (2005): 986-9. Link to SFX for this item
18. Blei, A T T. "Hepatic Encephalopathy." The American journal of gastroenterology 96.7 (2001): 1968-76. Link to SFX for this item
19. Nicolao, P. "Neurological toxicity of ifosfamide." Oncology 65.2 (2003): 11-6. Link to SFX for this item
20. Kircheis, K. "The treatment of hepatic encephalopathy." Metabolic brain disease 22.3-4 (2008): 389-405. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced